A review of the effects of the oral direct thrombin inhibitor ximelagatran on coagulation assays

被引:29
作者
Carlsson, SC [1 ]
Mattsson, C
Eriksson, UG
Sarich, TC
Wåhlander, K
Eliasson, Å
Karlson, BW
Sheth, SB
Held, P
机构
[1] AstraZeneca R&D, Molndal, Sweden
[2] AstraZeneca LP, Wilmington, DE USA
关键词
activated clotting time; activated partial thromboplastin time; blood coagulation tests; ecarin clotting time; oral direct thrombin inhibitors; prothrombin time; thrombin clotting time; ximelagatran;
D O I
10.1016/j.thromres.2004.07.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:9 / 18
页数:10
相关论文
共 60 条
[31]   Determination of melagatran, a novel, direct thrombin inhibitor, in human plasma and urine by liquid chromatography-mass spectrometry [J].
Larsson, M ;
Logren, U ;
Ahnoff, M ;
Lindmark, B ;
Abrahamsson, P ;
Svennberg, H ;
Persson, BA .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 766 (01) :47-55
[32]   In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation [J].
Linkins, LA ;
Julian, JA ;
Rischke, J ;
Hirsh, J ;
Weitz, JI .
THROMBOSIS RESEARCH, 2002, 107 (05) :241-244
[33]  
Mattsson C, 2001, THROMB HAEMOSTASIS, V86, P611
[34]   Quantitative determination of hirudin in blood and body fluids [J].
Nowak, G ;
Bucha, E .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1996, 22 (02) :197-202
[35]  
OWREN PA, 1959, LANCET, V2, P754
[36]  
OWREN PA, 1951, SCAND J CLIN LAB INV, V3, P201, DOI 10.3109/00365515109060600
[37]   Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation - SPORTIF II: A dose-guiding, tolerability, and safety study [J].
Petersen, P ;
Grind, M ;
Adler, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (09) :1445-1451
[38]  
POLLER L, 1980, SCAND J HAEMATOL, V25, P49
[39]   Monitoring of recombinant hirudin: Assessment of a plasma-based ecarin clotting time assay [J].
Potzsch, B ;
Hund, S ;
Madlener, K ;
Unkrig, C ;
MullerBerghaus, G .
THROMBOSIS RESEARCH, 1997, 86 (05) :373-383
[40]   A study of the coagulation defect in hemophilia and in jaundice [J].
Quick, AJ ;
Stanley-Browne, M ;
Bancroft, FW .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1935, 190 :501-511